Quick Answer
IMMUCELL CORP /DE/ reported Total Revenue of $27.64 million for the year ending 2025.
- IMMUCELL CORP /DE/ showed an increase of +4.3% in Total Revenue from 2024 to 2025.
- This data is from IMMUCELL CORP /DE/'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2023 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2023: $5.40 million | Q1 2024: $7.26 million | Q2 2024: $5.47 million | Q3 2024: $6.01 million | Q3 2024: $6.01 million | Q1 2025: $8.07 million | Q2 2025: $6.44 million | Q3 2025: $5.51 million.
- Over the full 4 years of available data (2023 to 2025), IMMUCELL CORP /DE/'s Total Revenue has grown by 58.2%.
- Historical annual values: Fiscal year 2025: $27.64 million | Fiscal year 2024: $26.49 million | Fiscal year 2024: $26.49 million | Fiscal year 2023: $17.47 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: